142 related articles for article (PubMed ID: 29802342)
1. Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation.
Ji Z; He L; Rotem A; Janzer A; Cheng CS; Regev A; Struhl K
Nat Commun; 2018 May; 9(1):2068. PubMed ID: 29802342
[TBL] [Abstract][Full Text] [Related]
2. The ETS transcription factor ESE-1 transforms MCF-12A human mammary epithelial cells via a novel cytoplasmic mechanism.
Prescott JD; Koto KS; Singh M; Gutierrez-Hartmann A
Mol Cell Biol; 2004 Jun; 24(12):5548-64. PubMed ID: 15169914
[TBL] [Abstract][Full Text] [Related]
3. Reconstruction of gene regulatory networks reveals chromatin remodelers and key transcription factors in tumorigenesis.
Malysheva V; Mendoza-Parra MA; Saleem MA; Gronemeyer H
Genome Med; 2016 May; 8(1):57. PubMed ID: 27198694
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional master regulator analysis in breast cancer genetic networks.
Tovar H; García-Herrera R; Espinal-Enríquez J; Hernández-Lemus E
Comput Biol Chem; 2015 Dec; 59 Pt B():67-77. PubMed ID: 26362298
[TBL] [Abstract][Full Text] [Related]
5. Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model.
Zhao QY; Lei PJ; Zhang X; Zheng JY; Wang HY; Zhao J; Li YM; Ye M; Li L; Wei G; Wu M
Clin Epigenetics; 2016; 8():34. PubMed ID: 27034728
[TBL] [Abstract][Full Text] [Related]
6. STAT3 acts through pre-existing nucleosome-depleted regions bound by FOS during an epigenetic switch linking inflammation to cancer.
Fleming JD; Giresi PG; Lindahl-Allen M; Krall EB; Lieb JD; Struhl K
Epigenetics Chromatin; 2015; 8():7. PubMed ID: 25784959
[TBL] [Abstract][Full Text] [Related]
7. The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment.
Turpin J; Ling C; Crosby EJ; Hartman ZC; Simond AM; Chodosh LA; Rennhack JP; Andrechek ER; Ozcelik J; Hallett M; Mills GB; Cardiff RD; Gray JW; Griffith OL; Muller WJ
Oncogene; 2016 Nov; 35(47):6053-6064. PubMed ID: 27157621
[TBL] [Abstract][Full Text] [Related]
8. A model for the epigenetic switch linking inflammation to cell transformation: deterministic and stochastic approaches.
Gérard C; Gonze D; Lemaigre F; Novák B
PLoS Comput Biol; 2014 Jan; 10(1):e1003455. PubMed ID: 24499937
[TBL] [Abstract][Full Text] [Related]
9. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
[TBL] [Abstract][Full Text] [Related]
10. 'Traffic light rules': Chromatin states direct miRNA-mediated network motifs running by integrating epigenome and regulatome.
Zhao H; Zhang G; Pang L; Lan Y; Wang L; Yu F; Hu J; Li F; Zhao T; Xiao Y; Li X
Biochim Biophys Acta; 2016 Jul; 1860(7):1475-88. PubMed ID: 27091612
[TBL] [Abstract][Full Text] [Related]
11. Epigenomic analysis in a cell-based model reveals the roles of H3K9me3 in breast cancer transformation.
Li QL; Lei PJ; Zhao QY; Li L; Wei G; Wu M
Epigenomics; 2017 Aug; 9(8):1077-1092. PubMed ID: 28762778
[TBL] [Abstract][Full Text] [Related]
12. Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancers.
Osmanbeyoglu HU; Shimizu F; Rynne-Vidal A; Alonso-Curbelo D; Chen HA; Wen HY; Yeung TL; Jelinic P; Razavi P; Lowe SW; Mok SC; Chiosis G; Levine DA; Leslie CS
Nat Commun; 2019 Sep; 10(1):4369. PubMed ID: 31554806
[TBL] [Abstract][Full Text] [Related]
13. LINC00520 is induced by Src, STAT3, and PI3K and plays a functional role in breast cancer.
Henry WS; Hendrickson DG; Beca F; Glass B; Lindahl-Allen M; He L; Ji Z; Struhl K; Beck AH; Rinn JL; Toker A
Oncotarget; 2016 Dec; 7(50):81981-81994. PubMed ID: 27626181
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta-induced transcriptional activation of MMP-2 is mediated by activating transcription factor (ATF)2 in human breast epithelial cells.
Kim ES; Sohn YW; Moon A
Cancer Lett; 2007 Jul; 252(1):147-56. PubMed ID: 17258390
[TBL] [Abstract][Full Text] [Related]
15. Molecular signatures associated with transformation and progression to breast cancer in the isogenic MCF10 model.
Rhee DK; Park SH; Jang YK
Genomics; 2008 Dec; 92(6):419-28. PubMed ID: 18804527
[TBL] [Abstract][Full Text] [Related]
16. Acquisition of stable inducible up-regulation of nuclear factor-kappaB by tumor necrosis factor exposure confers increased radiation resistance without increased transformation in breast cancer cells.
Braunstein S; Formenti SC; Schneider RJ
Mol Cancer Res; 2008 Jan; 6(1):78-88. PubMed ID: 18234964
[TBL] [Abstract][Full Text] [Related]
17. Identification of transcription factors that may reprogram lung adenocarcinoma.
Liu C; Zhang YH; Huang T; Cai Y
Artif Intell Med; 2017 Nov; 83():52-57. PubMed ID: 28377053
[TBL] [Abstract][Full Text] [Related]
18. Genetic reconstruction of a functional transcriptional regulatory network.
Hu Z; Killion PJ; Iyer VR
Nat Genet; 2007 May; 39(5):683-7. PubMed ID: 17417638
[TBL] [Abstract][Full Text] [Related]
19. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells.
Kim DW; Gazourian L; Quadri SA; Romieu-Mourez R; Sherr DH; Sonenshein GE
Oncogene; 2000 Nov; 19(48):5498-506. PubMed ID: 11114727
[TBL] [Abstract][Full Text] [Related]
20. Time-course gene profiling and networks in demethylated retinoblastoma cell line.
Malusa F; Taranta M; Zaki N; Cinti C; Capobianco E
Oncotarget; 2015 Sep; 6(27):23688-707. PubMed ID: 26143641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]